As Spring approaches, we see industry-wide destocking coming to an end, emerging recovery trends in China gaining momentum and European spot energy cost relief rolling in, all helping to restore plant utilisation and earnings. We add more cyclicality to our preferred names, upgrading BASF to Outperform (Neutral). Momentum being regained in specialties chemicals distribution triggers our upgrade of IMCD to Outperform (Neutral). ‘From record to record’ remains our mantra at FUCHS. ...
Moody's Ratings has completed a periodic review of the ratings of Edgewell Personal Care Company and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 14 March 2024 in which Moody's reassessed the appropriateness of the ratings in the co...
With momentum around electrification less favourable of late, we have seen a major shift in perception, from doubtless overly rose-tinted optimism to what looks to be similarly excessive pessimism. While we have reduced our BEV assumptions, we nonetheless still anticipate growth in the next few years (including this year), well ahead of that of the automotive market as a whole. In the face of these changes, the players in the value chain (mines, semiconductors, auto) are differently p...
Le momentum autour de l’électrification, moins favorable dernièrement, a conduit à un changement profond de perception, passant d’un optimisme sans doute excessif à un pessimisme qui le semble tout autant. En effet, si nous avons revu en baisse nos hypothèses, nous visons néanmoins toujours une croissance dans les années à venir (y compris cette année), bien supérieure à celle du marché automobile dans son ensemble. Face à ces changements, tous les acteurs au sein de la chaîne de vale...
>CMD did not deliver what many investors had hoped for - In recent months, many hopes were pinned on the CMD on 5 March, which was expected to provide more clarity on Bayer's strategic direction. In particular, how to tackle the high level of debt that currently limits financial flexibility, e.g. to invest in the weakening pharma pipeline. At the same time, hopes for a major strategic move, such as the separation of the Consumer Health (CH) division, had already faded...
Elis: new bond issue maturing in 2030Ageas: BNP is said to weigh purchase of Fosun’s Ageas stakeVodafone reaches an agreement to sell Vodafone Italy to Swisscom for € 2bn in cashTHOM: resilient Q1 results without any major surprise after the figures released as part of the issuance.>...
Elis : émission d’une nouvelle obligation à échéance 2030Ageas : BNP considérerait la reprise de la participation de 10% de Fosun au capital d’AgeasVodafone annonce un accord de cession de Vodafone Italie à Swisscom pour 8 mds EUR en cashTHOM : des résultats T1 résilients mais sans surprise après les chiffres communiqués dans le cadre de l’émission>...
A director at Allegion Plc sold after exercising options/sold 12,427 shares at 129.990USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: GRIFOLS, OHLA, TELEFONICA. EUROPA: BAYER, SIEMENS. El Ibex salva la jornada A la espera del dato de inflación de hoy en EE.UU., que pueda dar pistas sobre el comienzo de las bajadas de tipos por parte de la Fed, la jornada fue de recogidas de beneficios para la mayoría de índices europeos, a excepción del Ibex (ha subido en 6 de las últimas 7 sesiones). Así, en el STOXX 600, la mayoría de los sectores cerraron con caídas, lideradas por Tecnología y ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.